Category: Debt: Credit Risk |
Launch Date: 08-01-2015 |
Asset Class: Fixed Income |
Benchmark: CRISIL Credit Risk Fund CIII Index |
TER: 0.79% As on (31-03-2024) |
Status: Open Ended Schemes |
Minimum Investment: 5000.0 |
Minimum Topup: 1000.0 |
Total Assets: 153.57 Cr As on (31-03-2024) |
Turn over: - | Exit Load: For units in excess of 10% of the investment |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The primary objective of the Scheme is to generate returns by investing in debt and money market instruments across the credit spectrum. There is no assurance or guarantee that the investment objective of the Scheme will be realized.
Standard Deviation | 4.41 |
Sharpe Ratio | 0.97 |
Alpha | 2.85 |
Beta | -0.75 |
Yield to Maturity | 8.7 |
Average Maturity | 3.39 |
Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
---|---|---|---|---|---|---|
Baroda BNP Paribas Credit Risk Fund -Direct-Growth Option | 08-01-2015 | 8.18 | 7.34 | 9.58 | 7.91 | - |
DSP Credit Risk Fund - Regular Plan -Growth | 05-05-2003 | 15.16 | 9.96 | 9.48 | 7.22 | 6.98 |
Invesco India Credit Risk Fund - Regular Plan - Growth | 04-09-2014 | 7.8 | 7.85 | 6.06 | 5.38 | - |
Nippon India Credit Risk Fund - Growth Plan | 01-06-2005 | 7.62 | 6.64 | 8.42 | 4.12 | 6.22 |
Kotak Credit Risk Fund - Growth | 01-05-2010 | 7.48 | 4.61 | 4.6 | 5.73 | 7.09 |
ICICI Prudential Credit Risk Fund - Growth | 05-12-2010 | 7.42 | 6.7 | 6.53 | 7.55 | 7.98 |
Baroda BNP Paribas Credit Risk Fund -Regular-Growth Option | 23-01-2015 | 7.33 | 6.48 | 8.73 | 7.07 | - |
HDFC Credit Risk Debt Fund - Growth Option | 05-03-2014 | 7.05 | 6.14 | 6.02 | 7.42 | 8.02 |
Axis Credit Risk Fund - Regular Plan - Growth | 15-07-2014 | 6.88 | 6.18 | 5.76 | 5.88 | - |
Aditya Birla Sun Life Credit Risk Fund - Regular Plan - Growth | 05-04-2015 | 6.84 | 7.55 | 6.7 | 6.52 | - |
Minimum investment in corporate bonds - 65% of total assets (investment in below highest rated instruments).
Others
100.0%